Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
Christina Danial, Kavita Y. Sarin, Anthony E. Oro, et al.
Clinical Cancer Research (2015) Vol. 22, Iss. 6, pp. 1325-1329
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 310-320
Open Access | Times Cited: 1597
Stem cell fate in cancer growth, progression and therapy resistance
Nikki K. Lytle, Alison G. Barber, Tannishtha Reya
Nature reviews. Cancer (2018) Vol. 18, Iss. 11, pp. 669-680
Open Access | Times Cited: 557
Basal cell carcinoma
Michael C. Cameron, Erica Lee, Brian P. Hibler, et al.
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 2, pp. 303-317
Closed Access | Times Cited: 410
Guidelines of care for the management of basal cell carcinoma
John Y. S. Kim, Jeffrey H. Kozlow, Bharat B. Mittal, et al.
Journal of the American Academy of Dermatology (2018) Vol. 78, Iss. 3, pp. 540-559
Open Access | Times Cited: 402
Hedgehog Signaling: From Basic Biology to Cancer Therapy
Fujia Wu, Yu Zhang, Bo Sun, et al.
Cell chemical biology (2017) Vol. 24, Iss. 3, pp. 252-280
Open Access | Times Cited: 285
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, et al.
Journal of the National Comprehensive Cancer Network (2016) Vol. 14, Iss. 5, pp. 574-597
Open Access | Times Cited: 260
Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells
Ita Novita Sari, Lan Thi Phi, Nayoung Jun, et al.
Cells (2018) Vol. 7, Iss. 11, pp. 208-208
Open Access | Times Cited: 167
Non-Melanoma Skin Cancers: Biological and Clinical Features
Mauro Cives, Francesco Mannavola, Lucia Lospalluti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5394-5394
Open Access | Times Cited: 159
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Ngoc Minh Nguyen, Jungsook Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1733-1733
Open Access | Times Cited: 86
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
Evan J. Lipson, Mohammed Lilo, Aleksandra Ogurtsova, et al.
Journal for ImmunoTherapy of Cancer (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 137
Basal cell carcinoma
Michael C. Cameron, Erica Lee, Brian P. Hibler, et al.
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 2, pp. 321-339
Closed Access | Times Cited: 132
The emergence of drug resistance to targeted cancer therapies: Clinical evidence
Ana Bela Sarmento‐Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 47, pp. 100646-100646
Closed Access | Times Cited: 112
Hedgehog signaling inhibitors in solid and hematological cancers
Jorge E. Cortés, Ralf Gutzmer, Mark W. Kieran, et al.
Cancer Treatment Reviews (2019) Vol. 76, pp. 41-50
Open Access | Times Cited: 108
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma
Audrey A. Jacobsen, Adam S. Aldahan, Olivia Hughes, et al.
JAMA Dermatology (2016) Vol. 152, Iss. 7, pp. 816-816
Open Access | Times Cited: 102
Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
Michael R. Savona, Daniel A. Pollyea, Wendy Stock, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 10, pp. 2294-2303
Open Access | Times Cited: 97
Emerging trends in the treatment of advanced basal cell carcinoma
Michael R. Migden, Anne Lynn S. Chang, Luc Dirix, et al.
Cancer Treatment Reviews (2017) Vol. 64, pp. 1-10
Open Access | Times Cited: 91
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer
Richard L. Carpenter, Haimanti Ray
Drug Safety (2019) Vol. 42, Iss. 2, pp. 263-279
Open Access | Times Cited: 86
Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis
Pingxing Xie, Philippe Lefrançois
Journal of the American Academy of Dermatology (2018) Vol. 79, Iss. 6, pp. 1089-1100.e17
Closed Access | Times Cited: 84
Targeting Hedgehog signaling pathway: Paving the road for cancer therapy
Ali Salaritabar, Ioana Berindan‐Neagoe, Behrad Darvish, et al.
Pharmacological Research (2019) Vol. 141, pp. 466-480
Closed Access | Times Cited: 77
Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
Manni Wang, Wu Min
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 44
Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities
Stefano Sol, Fabiana Boncimino, Kristina Todorova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7056-7056
Open Access | Times Cited: 8
Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas
Sachin Jain, Ruolan Song, Jingwu Xie
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 1645-1653
Open Access | Times Cited: 87
Vismodegib: A Review in Advanced Basal Cell Carcinoma
James E. Frampton, Nicole Basset‐Séguin
Drugs (2018) Vol. 78, Iss. 11, pp. 1145-1156
Closed Access | Times Cited: 79
Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance
Yazmin Brown, Susan Hua, Pradeep S. Tanwar
The International Journal of Biochemistry & Cell Biology (2019) Vol. 109, pp. 90-104
Closed Access | Times Cited: 75
Page 1 - Next Page

Scroll to top